DOPEGYT

This brand name is authorized in Germany, Estonia, Hong Kong, Lithuania, Poland, Romania

Active ingredients

The drug DOPEGYT contains one active pharmaceutical ingredient (API):

1 Alphamethyldopa UNII 56LH93261Y - METHYLDOPA

Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors. Read about Alphamethyldopa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02AB	Methyldopa	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting
Discover more medicines within C02AB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 04630287
Country: EE	Ravimiamet	Identifier(s): 1095331, 1781434
Country: HK	Department of Health Drug Office	Identifier(s): 28038
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000656
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100020360, 100325549, 100449990, 100454059, 100455650, 100456143, 100456150, 100461571, 100463816, 100467695
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W04208001